ENCC — LLMpedia

ENCC
Name	ENCC

Contents

ENCC

Definition and Overview

ENCC are a migratory cell population first described in embryological studies by investigators associated with Santiago Ramón y Cajal, Camillo Golgi, Wilhelm His Sr., Franklin P. Mall and later synthesized into concepts by researchers at institutions such as Johns Hopkins University, University of Cambridge, Harvard Medical School, University of Paris and Max Planck Society. Contemporary surveys in journals published by Nature Publishing Group, Elsevier, Wiley-Blackwell, Springer and Cell Press frame ENCC within comparative studies involving Xenopus laevis, Gallus gallus domesticus, Mus musculus, Danio rerio and Homo sapiens. Reviews citing work from laboratories led by investigators affiliated with Stanford University, Massachusetts General Hospital, Göttingen University, University of Tokyo and Wellcome Trust Sanger Institute discuss ENCC alongside related cell lineages characterized in projects funded by the National Institutes of Health, European Research Council, Wellcome Trust and Howard Hughes Medical Institute.

Classic fate-mapping experiments performed by teams at Carnegie Institution for Science, Cold Spring Harbor Laboratory, University of Edinburgh, Columbia University, and Yale University traced ENCC emergence from regions adjacent to structures described in treatises by Henrietta Lacks-era tissue studies and modern single-cell atlases produced by consortia including the Human Cell Atlas and the Allen Institute for Brain Science. Genetic regulatory networks implicating transcription factors such as SOX10, RET, PHOX2B, EDNRB and GATA2 were elucidated in molecular genetics work involving laboratories at The Salk Institute, Broad Institute, The Francis Crick Institute and Imperial College London. Classic signaling pathways taught in reviews from Developmental Cell, Genes & Development, Nature Neuroscience, Proceedings of the National Academy of Sciences and The Journal of Cell Biology—for example interactions among WNT1, BMP4, GDNF, Notch1 and FGF8—are invoked to explain migration, proliferation and lineage specification of ENCC in vertebrate embryos used by researchers at Uppsala University, University of California, San Diego, McGill University and Seoul National University.

Anatomic mapping studies published by teams from National Institutes of Health Clinical Center, Mayo Clinic, Cleveland Clinic, Karolinska Institutet and John Radcliffe Hospital document ENCC presence within the developing tubular structures studied by comparative anatomists at Natural History Museum, London, Smithsonian Institution, Muséum national d'Histoire naturelle and Linnean Society of London. Detailed atlases produced by collaborations including European Molecular Biology Laboratory, Wellcome Sanger Institute, Institut Pasteur and Max Planck Institute for Molecular Genetics localize ENCC to concentric layers adjacent to epithelia described in classic texts from Gray's Anatomy, Netter's Atlas of Human Anatomy, Sobotta Atlas of Human Anatomy and papers from The Lancet, BMJ and JAMA. Distribution patterns are compared across taxa such as Xenopus tropicalis, Anolis carolinensis, Gallus domesticus, Mus musculus and Homo sapiens in comparative morphology studies led by teams at University of California, Berkeley, Australian National University and University of Toronto.

Functional assays performed in laboratories at University College London, Princeton University, University of Michigan, ETH Zurich and University of Sydney correlate ENCC-derived circuitry with reflexes and motility modules described in physiology texts from Guyton and Hall, experimental studies in Journal of Physiology, American Journal of Physiology and neurogastroenterology reports in Gastroenterology. Electrophysiological recordings performed using methods developed at MIT Koch Institute, Bell Labs-era techniques, and contemporary platforms from Oxford Nanopore Technologies and Illumina-based expression profiling link ENCC function to neurotransmitters and receptors associated with acetylcholine, serotonin, nitric oxide synthase, neuropeptide Y and substance P, with molecular characterization contributed by groups at Scripps Research, University of California, San Francisco and University of Pennsylvania.

Clinical genetics consortia including Deciphering Developmental Disorders Study, ClinGen and centers such as Great Ormond Street Hospital, Boston Children's Hospital, Seattle Children's Hospital and Baylor College of Medicine associate ENCC dysfunction with congenital conditions described in case series from The New England Journal of Medicine, Nature Medicine and European Journal of Human Genetics. Syndromes and phenotypes linked via mutations in RET, SOX10, EDNRB, PHOX2B and GDNF appear in clinical guidelines from American College of Medical Genetics and Genomics, European Society of Human Genetics and specialty reviews from Society for Pediatric Research and International Pediatric Association. Pathologic states characterized in surgical literature from Annals of Surgery, Surgery, British Journal of Surgery and reports from tertiary centers such as Johns Hopkins Hospital, Mayo Clinic and Cleveland Clinic include obstructive, dysmotility and aganglionosis presentations requiring multidisciplinary care.

Diagnostic pathways described in consensus statements from American Gastroenterological Association, European Union of Medical Specialists, Pediatric Academic Societies and technical reports from Society of Nuclear Medicine and Molecular Imaging integrate histopathology methods refined at The Royal College of Pathologists, immunohistochemical panels validated by laboratories at Memorial Sloan Kettering Cancer Center and molecular testing workflows used by clinical laboratories at Molecular Diagnostics Laboratory, University of Washington Medical Center and Mayo Clinic Laboratories. Imaging modalities reviewed in articles from Radiology, AJR American Journal of Roentgenology and multicenter trials from National Institutes of Health combine contrast studies, ultrasound, magnetic resonance imaging platforms developed by GE Healthcare, Siemens Healthineers and Philips Healthcare with biopsy protocols established in pediatric surgical series from Great Ormond Street Hospital and SickKids Hospital.

Therapeutic strategies emerging from randomized trials and cohort studies reported in The Lancet, New England Journal of Medicine and specialty surgery literature at Annals of Surgery and Journal of Pediatric Surgery include surgical resections pioneered at centers such as Boston Children's Hospital, Great Ormond Street Hospital and Hospital for Sick Children (Toronto), alongside enteric rehabilitation programs developed by multidisciplinary teams at Mayo Clinic, Cleveland Clinic and Johns Hopkins Hospital. Adjunct approaches informed by translational research at University of Freiburg, Leiden University Medical Center, Karolinska Institutet and biotech firms in accelerator programs supported by Bill & Melinda Gates Foundation and Wellcome Trust explore cell-therapy, gene-editing strategies referencing CRISPR-Cas9, stem cell-derived organoids modeled in laboratories at Hubrecht Institute and pharmacological modulation targeting pathways involving GDNF, RET, WNT and NOTCH.